Artios Pharma
PrivateLast Round
Series D
Nov 17, 2025
Total Funding Raised
$500.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Artios Pharma is a biotechnology company developing a pipeline of cancer treatments that target the DNA Damage Response (DDR) process.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artios Pharma Comparables
Compare Artios Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Repare Therapeutics | 82% | |
| FoRx Therapeutics | 79% | |
| Breakpoint Therapeutics | 79% | |
Artios Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 17, 2025 | ||||
| Series D | Nov 17, 2023 | ||||
| Series C | Jul 27, 2021 | ||||
| Series B | Aug 10, 2018 | ||||
| Series A | Sep 21, 2016 |
Artios Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Series C |
| Janus Henderson Group | Series D |
| RA Capital Management | Series D |
| TCG Crossover | Series C |
| Omega Funds | Series D, Series C |
| EQT Life Sciences | Series D, Series C, Series B |
| SV Health Investors | Series B, Series C, Series D, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 16, 2026
Roy W. Ware joins to lead CMSC operations for therapeutics pipeline.
- Jan 7, 2026
Will present at the 44th Annual J.P. Morgan Healthcare Conference.
Artios Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Artios Pharma's valuation, stock price, and market status.